Atrial Fibrillation Symposium 2023 gave an insight into new technologies for atrial fibrillation, atrial fibrillation ablation and left atrial appendage closure. In this touchCARDIO interview, we speak with Prof. Luigi Di Biase (Albert Einstein College of Medicine, Montefiore Health System, New York, NY, USA) to discuss his highlights from the Atrial Fibrillation Symposium, 2–4 February […]

Radiofrequency and cryoablation have been the standard treatment options for atrial fibrillation ablation in recent decades. A new energy source has recently received a CE mark showing promise for atrial fibrillation patients. In this touchCARDIO interview, we speak with Prof. Luigi Di Biase (Albert Einstein College of Medicine, Montefiore Health System, New York, NY, USA) […]

Atrial fibrillation (AF) is a common heart rhythm disorder that increases with age and affects approximately 1-2% of the general population. The risk of developing AF is influenced by various factors, including age, gender, hypertension, diabetes, obesity, and underlying heart disease. Dr Shaan Khurshid (Massachusetts General Hospital, Boston, MA, USA) discusses the incidence and risk […]

 Artificial intelligence Atrial Fibrillation Shaan Khurshid AF Symposium 2023 Artificial intelligence (AI) has shown promise in predicting atrial fibrillation (AF) risk by analyzing various patient data such as demographics, medical history, and electrocardiogram (ECG) recordings, which can potentially help identify high-risk patients and facilitate early interventions to prevent AF-related complications. Dr Shaan Khurshid (Massachusetts General Hospital, Boston, […]

Atrial fibrillation (AF) is common place across the United States and globally, with high prevalence and complication of stroke. In this touchCARDIO interview, we speak with Dr Aloke Finn (Medical Director, CVpath Institute; Associate Professor, University of Maryland, College Park, MD, USA) to discuss healing following left atrial appendage (LAA) closure and the use of devices […]

AF Symposium 2023 Atrial Fibrillation Stroke  Left atrial appendage occlusion (LAAO) devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. AF Symposium is a highly focused three-day symposium bringing together the world’s leading medical scientists to share in a […]

The advantages and challenges of peri and post procedural anticoagulation with LAA closure devices were discussed by Prof. Luigi Di Biase in a short interview with touchCARDIO, at the annual AF Symposium 2022. The abstract entitled ‘Peri and Post Procedural Anticoagulation with LAA Closure Devices – An Evolving Story’ was presented at the annual AF […]

Highlights in pulse-field ablation for atrial fibrillation from the annual AF Symposium were discussed by Dr Atul Verma (Southlake Regional Health Centre, Newmarket, Ontorio, Canada) in a short interview with touchCARDIO. The abstract entitled ‘The Globe PF System: A Complete Solution for High-Definition Mapping and Pulsed-Field Ablation for AF’ was presented at the annual AF […]

The clinical outcomes of the Globe PF system use in HD mapping and pulsed-field ablation for atrial fibrillation, are discussed in this touchCARDIO interview with Dr Atul Verma (Southlake Regional Health Centre, Newmarket, Ontorio, Canada). Pulsed field ablation is an innovative therapy that uses electric fields to treat heart tissue. PFA delivered by the Globe […]